{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T06:12:43Z","timestamp":1784182363081,"version":"3.55.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T00:00:00Z","timestamp":1778889600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"vor","delay-in-days":61,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-53314-9","type":"journal-article","created":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T10:04:32Z","timestamp":1778925872000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of hospital safety-net status on in-hospital and short-outcomes after hematopoietic stem cell transplantation"],"prefix":"10.1038","volume":"16","author":[{"given":"Qi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjing","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuyan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,16]]},"reference":[{"key":"53314_CR1","doi-asserted-by":"publisher","first-page":"e177","DOI":"10.1016\/j.bbmt.2020.04.013","volume":"26","author":"A D'Souza","year":"2020","unstructured":"D\u2019Souza, A. et al. Current use of and trends in hematopoietic cell transplantation in the United States. Biol. Blood Marrow Transplant. 26, e177\u2013e182. https:\/\/doi.org\/10.1016\/j.bbmt.2020.04.013 (2020).","journal-title":"Biol. Blood Marrow Transplant."},{"key":"53314_CR2","doi-asserted-by":"publisher","first-page":"2940","DOI":"10.1038\/s41409-021-01431-6","volume":"56","author":"LP Xu","year":"2021","unstructured":"Xu, L. P. et al. Hematopoietic stem cell transplantation activity in China 2019: A report from the Chinese Blood and Marrow Transplantation Registry Group. Bone Marrow Transplant. 56, 2940\u20132947. https:\/\/doi.org\/10.1038\/s41409-021-01431-6 (2021).","journal-title":"Bone Marrow Transplant."},{"key":"53314_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-018-0564-x","volume":"11","author":"L Xu","year":"2018","unstructured":"Xu, L. et al. The consensus on indications, conditioning regimen, and donor selection of allogeneic hematopoietic cell transplantation for hematological diseases in China-recommendations from the Chinese Society of Hematology. J. Hematol. Oncol. 11, 33. https:\/\/doi.org\/10.1186\/s13045-018-0564-x (2018).","journal-title":"J. Hematol. Oncol."},{"key":"53314_CR4","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/bmt.2016.18","volume":"51","author":"D Niederwieser","year":"2016","unstructured":"Niederwieser, D. et al. Hematopoietic stem cell transplantation activity worldwide in 2012 and a SWOT analysis of the Worldwide Network for Blood and Marrow Transplantation Group including the global survey. Bone Marrow Transplant. 51, 778\u2013785. https:\/\/doi.org\/10.1038\/bmt.2016.18 (2016).","journal-title":"Bone Marrow Transplant."},{"key":"53314_CR5","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1038\/bmt.2017.59","volume":"52","author":"LP Xu","year":"2017","unstructured":"Xu, L. P. et al. A review of hematopoietic cell transplantation in China: Data and trends during 2008-2016. Bone Marrow Transplant. 52, 1512\u20131518. https:\/\/doi.org\/10.1038\/bmt.2017.59 (2017).","journal-title":"Bone Marrow Transplant."},{"key":"53314_CR6","doi-asserted-by":"publisher","first-page":"e91","DOI":"10.1016\/s2352-3026(15)00028-9","volume":"2","author":"A Gratwohl","year":"2015","unstructured":"Gratwohl, A. et al. One million haemopoietic stem-cell transplants: a retrospective observational study. Lancet Haematol 2, e91-100. https:\/\/doi.org\/10.1016\/s2352-3026(15)00028-9 (2015).","journal-title":"Lancet Haematol"},{"key":"53314_CR7","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1038\/s41409-019-0748-1","volume":"55","author":"NS Majhail","year":"2020","unstructured":"Majhail, N. S. et al. Transplant center characteristics and survival after allogeneic hematopoietic cell transplantation in adults. Bone Marrow Transplant. 55, 906\u2013917. https:\/\/doi.org\/10.1038\/s41409-019-0748-1 (2020).","journal-title":"Bone Marrow Transplant."},{"key":"53314_CR8","doi-asserted-by":"publisher","first-page":"e355","DOI":"10.1200\/op.20.00170","volume":"17","author":"A Godara","year":"2021","unstructured":"Godara, A. et al. Length of stay and hospital costs for patients undergoing allogeneic stem-cell transplantation. JCO Oncol. Pract. 17, e355\u2013e368. https:\/\/doi.org\/10.1200\/op.20.00170 (2021).","journal-title":"JCO Oncol. Pract."},{"key":"53314_CR9","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1016\/j.bbmt.2017.03.012","volume":"23","author":"L Sanchez","year":"2017","unstructured":"Sanchez, L. et al. In-hospital mortality and post-transplantation complications in elderly multiple myeloma patients undergoing autologous hematopoietic stem cell transplantation: A population-based study. Biol. Blood Marrow Transplant. 23, 1203\u20131207. https:\/\/doi.org\/10.1016\/j.bbmt.2017.03.012 (2017).","journal-title":"Biol. Blood Marrow Transplant."},{"key":"53314_CR10","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s00277-018-3528-x","volume":"98","author":"C Marini","year":"2019","unstructured":"Marini, C. et al. Real-life data on safety and efficacy of autologous stem cell transplantation in elderly patients with multiple myeloma. Ann. Hematol. 98, 369\u2013379. https:\/\/doi.org\/10.1007\/s00277-018-3528-x (2019).","journal-title":"Ann. Hematol."},{"key":"53314_CR11","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1182\/bloodadvances.2023011033","volume":"8","author":"RT Maziarz","year":"2024","unstructured":"Maziarz, R. T. et al. Health care costs among patients with hematologic malignancies receiving allogeneic transplants: A US payer perspective. Blood Adv. 8, 1200\u20131208. https:\/\/doi.org\/10.1182\/bloodadvances.2023011033 (2024).","journal-title":"Blood Adv."},{"issue":"637","key":"53314_CR12","doi-asserted-by":"publisher","first-page":"e631","DOI":"10.1016\/j.jtct.2023.06.013","volume":"29","author":"RT Maziarz","year":"2023","unstructured":"Maziarz, R. T. et al. Estimating the Lifetime Medical Cost Burden of an Allogeneic Hematopoietic Cell Transplantation Patient. Transplant Cell Ther 29(637), e631-637.e639. https:\/\/doi.org\/10.1016\/j.jtct.2023.06.013 (2023).","journal-title":"Transplant Cell Ther"},{"key":"53314_CR13","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1016\/j.bbmt.2017.06.017","volume":"23","author":"MA Perales","year":"2017","unstructured":"Perales, M. A. et al. Real-world economic burden associated with transplantation-related complications. Biol. Blood Marrow Transplant. 23, 1788\u20131794. https:\/\/doi.org\/10.1016\/j.bbmt.2017.06.017 (2017).","journal-title":"Biol. Blood Marrow Transplant."},{"key":"53314_CR14","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1182\/blood-2012-05-426783","volume":"120","author":"N Khera","year":"2012","unstructured":"Khera, N., Zeliadt, S. B. & Lee, S. J. Economics of hematopoietic cell transplantation. Blood 120, 1545\u20131551. https:\/\/doi.org\/10.1182\/blood-2012-05-426783 (2012).","journal-title":"Blood"},{"key":"53314_CR15","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1093\/jnci\/djq495","volume":"103","author":"AB Mariotto","year":"2011","unstructured":"Mariotto, A. B., Yabroff, K. R., Shao, Y., Feuer, E. J. & Brown, M. L. Projections of the cost of cancer care in the United States: 2010-2020. J. Natl. Cancer Inst. 103, 117\u2013128. https:\/\/doi.org\/10.1093\/jnci\/djq495 (2011).","journal-title":"J. Natl. Cancer Inst."},{"key":"53314_CR16","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1016\/j.bbmt.2017.07.026","volume":"23","author":"D Weisdorf","year":"2017","unstructured":"Weisdorf, D., Ruiz-Arguelles, G. J., Srivastava, A., G\u00f3mez-Almaguer, D. & Szer, J. Economic challenges in hematopoietic cell transplantation: How will new and established programs face the growing costs?. Biol. Blood Marrow Transplant. 23, 1815\u20131816. https:\/\/doi.org\/10.1016\/j.bbmt.2017.07.026 (2017).","journal-title":"Biol. Blood Marrow Transplant."},{"key":"53314_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/pon.70032","volume":"33","author":"Q Zhang","year":"2024","unstructured":"Zhang, Q. et al. Psychological risk factors on hematopoietic stem cell transplantation patients: Insights from National Readmission Database analysis. Psychooncology 33, e70032. https:\/\/doi.org\/10.1002\/pon.70032 (2024).","journal-title":"Psychooncology"},{"key":"53314_CR18","doi-asserted-by":"publisher","first-page":"599","DOI":"10.6004\/jnccn.2020.0021","volume":"18","author":"A Saad","year":"2020","unstructured":"Saad, A. et al. Hematopoietic cell transplantation, version 2.2020, NCCN Clinical Practice Guidelines in Oncology. J. Natl. Compr. Canc. Netw. 18, 599\u2013634. https:\/\/doi.org\/10.6004\/jnccn.2020.0021 (2020).","journal-title":"J. Natl. Compr. Canc. Netw."},{"key":"53314_CR19","unstructured":"Sutton, J. P., Washington, R. E., Fingar, K. R. & Elixhauser, A. in Healthcare Cost and Utilization Project (HCUP) Statistical Briefs (Agency for Healthcare Research and Quality (US), 2006)."},{"key":"53314_CR20","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.surg.2024.03.036","volume":"176","author":"C Branche","year":"2024","unstructured":"Branche, C. et al. Utilization of minimally invasive colectomy at safety-net hospitals in the United States. Surgery 176, 172\u2013179. https:\/\/doi.org\/10.1016\/j.surg.2024.03.036 (2024).","journal-title":"Surgery"},{"key":"53314_CR21","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.amjcard.2019.05.037","volume":"124","author":"T Ando","year":"2019","unstructured":"Ando, T. et al. In-hospital outcomes of ST-segment elevation myocardial infarction complicated with cardiogenic shock at safety-net hospitals in the United States (from the Nationwide Inpatient Sample). Am. J. Cardiol. 124, 485\u2013490. https:\/\/doi.org\/10.1016\/j.amjcard.2019.05.037 (2019).","journal-title":"Am. J. Cardiol."},{"key":"53314_CR22","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1056\/NEJMra052638","volume":"354","author":"EA Copelan","year":"2006","unstructured":"Copelan, E. A. Hematopoietic stem-cell transplantation. N. Engl. J. Med. 354, 1813\u20131826. https:\/\/doi.org\/10.1056\/NEJMra052638 (2006).","journal-title":"N. Engl. J. Med."},{"key":"53314_CR23","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1002\/ajh.26763","volume":"98","author":"P Vittayawacharin","year":"2023","unstructured":"Vittayawacharin, P., Kongtim, P. & Ciurea, S. O. Allogeneic stem cell transplantation for patients with myelodysplastic syndromes. Am. J. Hematol. 98, 322\u2013337. https:\/\/doi.org\/10.1002\/ajh.26763 (2023).","journal-title":"Am. J. Hematol."},{"key":"53314_CR24","doi-asserted-by":"publisher","first-page":"929","DOI":"10.3324\/haematol.2018.200808","volume":"104","author":"N Gagelmann","year":"2019","unstructured":"Gagelmann, N. et al. Optimized EBMT transplant-specific risk score in myelodysplastic syndromes after allogeneic stem-cell transplantation. Haematologica 104, 929\u2013936. https:\/\/doi.org\/10.3324\/haematol.2018.200808 (2019).","journal-title":"Haematologica"},{"key":"53314_CR25","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1182\/blood.2020005811","volume":"135","author":"R Zeiser","year":"2020","unstructured":"Zeiser, R. Introduction to a how i treat series on major complications after allogeneic stem cell transplantation. Blood 135, 1609. https:\/\/doi.org\/10.1182\/blood.2020005811 (2020).","journal-title":"Blood"},{"key":"53314_CR26","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/j.surg.2019.06.020","volume":"166","author":"TC Lee","year":"2019","unstructured":"Lee, T. C. et al. Liver transplantation at safety net hospitals: Potentially vulnerable patients with noninferior outcomes. Surgery 166, 1135\u20131141. https:\/\/doi.org\/10.1016\/j.surg.2019.06.020 (2019).","journal-title":"Surgery"},{"key":"53314_CR27","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1016\/j.transproceed.2023.05.019","volume":"55","author":"L Lim","year":"2023","unstructured":"Lim, L. et al. The association between institutional case volume of hematopoietic stem cell transplantation and mortality. Transplant. Proc. 55, 1715\u20131725. https:\/\/doi.org\/10.1016\/j.transproceed.2023.05.019 (2023).","journal-title":"Transplant. Proc."},{"key":"53314_CR28","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1016\/j.ebiom.2015.11.021","volume":"2","author":"A Gratwohl","year":"2015","unstructured":"Gratwohl, A. et al. Economics and outcome after hematopoietic stem cell transplantation: A retrospective cohort study. EBioMedicine 2, 2101\u20132109. https:\/\/doi.org\/10.1016\/j.ebiom.2015.11.021 (2015).","journal-title":"EBioMedicine"},{"key":"53314_CR29","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1002\/ajh.24767","volume":"92","author":"VR Bhatt","year":"2017","unstructured":"Bhatt, V. R. et al. Early mortality and overall survival of acute myeloid leukemia based on facility type. Am. J. Hematol. 92, 764\u2013771. https:\/\/doi.org\/10.1002\/ajh.24767 (2017).","journal-title":"Am. J. Hematol."},{"key":"53314_CR30","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1377\/hlthaff.2014.0109","volume":"33","author":"ES Cole","year":"2014","unstructured":"Cole, E. S., Walker, D., Mora, A. & Diana, M. L. Identifying hospitals that may be at most financial risk from Medicaid disproportionate-share hospital payment cuts. Health Aff (Millwood) 33, 2025\u20132033. https:\/\/doi.org\/10.1377\/hlthaff.2014.0109 (2014).","journal-title":"Health Aff (Millwood)"},{"key":"53314_CR31","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1377\/hlthaff.2013.1222","volume":"33","author":"K Neuhausen","year":"2014","unstructured":"Neuhausen, K. et al. Disproportionate-share hospital payment reductions may threaten the financial stability of safety-net hospitals. Health Aff (Millwood) 33, 988\u2013996. https:\/\/doi.org\/10.1377\/hlthaff.2013.1222 (2014).","journal-title":"Health Aff (Millwood)"},{"key":"53314_CR32","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1001\/jamasurg.2015.3209","volume":"151","author":"RS Hoehn","year":"2016","unstructured":"Hoehn, R. S. et al. Effect of hospital safety-net burden on cost and outcomes after surgery. JAMA Surg. 151, 120\u2013128. https:\/\/doi.org\/10.1001\/jamasurg.2015.3209 (2016).","journal-title":"JAMA Surg."},{"key":"53314_CR33","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.12873","volume":"7","author":"AC Law","year":"2024","unstructured":"Law, A. C. et al. In-hospital vs 30-day sepsis mortality at US safety-net and non-safety-net hospitals. JAMA Netw. Open 7, e2412873. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.12873 (2024).","journal-title":"JAMA Netw. Open"},{"key":"53314_CR34","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.jcrc.2019.08.009","volume":"54","author":"IJ Barbash","year":"2019","unstructured":"Barbash, I. J. & Kahn, J. M. Sepsis quality in safety-net hospitals: An analysis of Medicare\u2019s SEP-1 performance measure. J. Crit. Care 54, 88\u201393. https:\/\/doi.org\/10.1016\/j.jcrc.2019.08.009 (2019).","journal-title":"J. Crit. Care"},{"key":"53314_CR35","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1001\/jamasurg.2023.7863","volume":"159","author":"L Ngo","year":"2024","unstructured":"Ngo, L., Quintero, L. & Parreco, J. P. Nationwide propensity-matched comparison of surgical site infections in safety net hospitals. JAMA Surg. 159, 588\u2013590. https:\/\/doi.org\/10.1001\/jamasurg.2023.7863 (2024).","journal-title":"JAMA Surg."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-53314-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-53314-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-53314-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T05:53:42Z","timestamp":1784181222000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-53314-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,16]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["53314"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-53314-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,16]]},"assertion":[{"value":"24 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Our study was conducted in accordance with the Declaration of Helsinki, and none of the transplanted organs or tissues came from prisoners. As all data from the NRD are de-identified, informed consent from individual patients was not required.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"22290"}}